Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_provenance.
- NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_assertion description "[Here, we demonstrate the successful application of a high-throughput gene-expression profiling assay directly targeting genes of the androgen receptor pathway to screen a natural products library leading to the identification of 17?-hydroxywithanolides 1-5, of which physachenolide D (5) exhibited potent and selective in vitro activity against two PC cell lines, LNCaP and PC-3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_provenance.
- NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_assertion evidence source_evidence_literature NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_provenance.
- NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_assertion SIO_000772 26305181 NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_provenance.
- NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_assertion wasDerivedFrom befree-2016 NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_provenance.
- NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_assertion wasGeneratedBy ECO_0000203 NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1293177.RA4rEt-0ejTj5PhT_CuBLd8RUqNf7UfKH1qqjd9id_tJQ130_provenance.